Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues DCH Q1 2026 Earnings Massive EPS Surprise Drives Stock Up 39 Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment DSGN Q1 2026 Earnings Narrowerthanexpected loss drives positive sentiment PSA Q1 2026 Earnings EPS Surpasses Estimates by 124 as Occupancy and Expense Control Drive Results GFL Q1 2026 Earnings EPS Misses Estimates Amidst Cost Pressures